Indications for use of Anaferon are:

Prevention and treatment of acute respiratory viral infections (including influenza).

Complex therapy of infections caused by herpes viruses (infectious mononucleosis, chickenpox, labial herpes, genital herpes).

Complex therapy and prevention of recurrence of chronic herpesvirus infection, including labial and genital herpes.

Complex therapy and prevention of other acute and chronic viral infections caused by tick-borne encephalitis virus, enterovirus, rotavirus, coronavirus, calicivirus.

Application in the complex therapy of bacterial infections

Complex therapy of secondary immunodeficiency states of various etiologies, including prevention and treatment of complications of viral and bacterial infections.

Pharmachologic effect:

With prophylactic and therapeutic use, the drug has an immunomodulatory and antiviral effect. Experimentally and clinically established effectiveness against influenza viruses, parainfluenza, herpes simplex viruses of types 1 and 2 (labial herpes, genital herpes), other herpes viruses (chickenpox, infectious mononucleosis), enteroviruses, tick-borne encephalitis virus, rotavirus, coronavirus, calicivirus , adenovirus, respiratory syncytial (PC virus). The drug reduces the concentration of the virus in the affected tissues, affects the system of endogenous interferons and associated cytokines, induces the formation of endogenous "early" interferons (IFN a / β) and interferon gamma (IFN γ).

Stimulates the humoral and cellular immune response. Increases the production of antibodies (including secretory IgA), activates the functions of T-effectors, T-helpers (Tx), and normalizes their ratio. Increases the functional reserve of Th and other cells involved in the immune response. It is an inducer of a mixed Txl and Th2-type immune response: it increases the production of cytokines Txl (IFN γ, IL-2) and Th2 (IL-4, 10), normalizes (modulates) the balance of Th1 / Th2 activities. Increases the functional activity of phagocytes and natural killer cells (EK cells). Possesses antimutagenic properties.

  Description:

Tablets are flat-cylindrical, with a scored and beveled, from white to almost white. The flat side with scribble has the inscription MATERIA MEDICA, the other flat side has the inscription ANAFERON.

  Pharmacokinetics:

The sensitivity of modern physicochemical methods of analysis (gas-liquid chromatography, high-performance liquid chromatography, gas chromatography-mass spectrometry) does not allow assessing the content of the active components of Anaferon in biological fluids, organs and tissues, which makes it technically impossible to study pharmacokinetics.